想要出国访问学习的小伙伴看过来啦，美国维克森林大学癌细胞免疫疗法方向正在招收招聘访问学者、博士后！
Dr. Lu’s Lab is seeking motivated, hardworking Candidate(s) with a background in immunology and/or cancer biology to take projects focused on understanding the role of the tumor microenvironment on CAR T cell therapy resistance.
Candidates with a background in bioinformatics are also preferred if they are willing to assess responses in cancer immunotherapy utilizing bioinformatics tools.
Please submit your application with the following information: a cover letter, statement of research interest, and CV with contact details for 3 references to: Yong Lu, Ph.D. Assistant Professor; Dept of Microbiology and Immunology; Wake Forest School of Medicine; yolu@wakehealth.edu
Dr. Lu’s Lab is a basic/translational research lab in the Wake Forest School of Medicine with an interest in cancer adoptive T cell immunotherapy.
Dr. Lu is one of the six NCI’s advisors to advise the NCI on future directions of Adoptive Cell Immunotherapy. The lab is now funded with R01, R00, ACS research scholar grant, pharmaceutical company-sponsored research, and many other grants from cancer foundations and intramural pilot research supports.
Dr. Lu’s lab utilizes state-of-the-art flow cytometry, CyTOF, single-cell RNA sequencing, bioinformatics, organoids and tumor models to investigate mechanisms of resistance to chimeric antigen receptor (CAR)-T cell adoptive therapy. Recent representative lab publications: Nature Comm 2019 (PMID: 30914642); Cancer Cell 2018 (PMID: 29894691); Nature Comm 2016 (PMID: 27492902); Nature Comm 2014 (PMID: 24957461); PNAS 2014 (PMID: 24469818); JCI 2012 (PMID: 23064366).
Qualifications:
Recent PhD、MD PhD or a visiting scholar graduate in cancer, immunology, bioinformatics or related discipline.
Experience with molecular biology, biochemistry and cell biology, cancer immunology, and cell culture (not required for the candidate in bioinformatics background).
Preferred familiarity with in vivo syngeneic mouse tumor models.
Independent, highly self-motivated and innovative.
Proven track record in the field of immunology/tumor immunology and/or oncology, with relevant publications.
Willing to seek out grant funding from external sources in support of their independent research and may participate in writing grant proposals.
Outstanding interpersonal skills, strong work ethic and organizational skills.
Ability to excel in a goal-oriented, multifaceted and fast-moving team environment.
院校简介：
维克森林大学（Wake Forest University），又译作维克弗里斯特大学，建于1834年，是美国一所极富盛名的综合性研究大学。因小班制精英教学体制，维克森林也被称作“南方哈佛”、“南方达特茅斯”。
维克森林大学连续21年位列全美大学综合排名25名左右 ，2018年US News美国大学排名中，维克森林大学位列全美27名 。“Strong Commitment to Teaching”全美本科教育质量排名在2017年US News达到第5名，前4名为普林斯顿大学、耶鲁大学、布朗大学 。
维克森林大学被誉为“常春藤的小后门”，意在学生在维克森林完成本科学业后有高于其他众多大学进入常春藤联盟顶尖大学继续接受更高等教育的机会。
该校在中国内地地区相对美国其他前30名校知名度较小，原因主要在于该校对招收国际学生相当严格，申请该校，学生需要递交5篇左右的命题作文 ，所以维克森林也是全美前30名校中国际学生人数最少的学校 。
维克森林大学坐落于美国北卡罗莱纳州历史名城温莎（Winston-Salem），距美国东南部地区最重要的金融、贸易和交通运输中心夏洛特市约一小时车程。维克商学院在Businessweek本科商学院中排名11 ，教学质量一项长期以来与常春藤盟校宾夕法尼亚大学的沃顿商学院并列全美第1名 。其会计硕士专业全球著名，10年来具有全美国第1的注册会计师考试通过率 （97%）及100%的毕业生就业率，遥遥领先于全国的平均水平。
热门跟贴